Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

1(7%)

Results Posted

80%(4 trials)

Terminated

2(14%)

Phase Distribution

Ph early_phase_1

14%

Ph not_applicable

21%

Ph phase_1

Ph phase_2

36%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Early Phase 1First-in-human

2(15.4%)

Phase 1Safety & dosage

1(7.7%)

Phase 2Efficacy & side effects

5(38.5%)

Phase 4Post-market surveillance

2(15.4%)

N/ANon-phased studies

3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(5)

Terminated(3)

Other(1)

Detailed Status

Completed5

Not yet recruiting3

Terminated2

Withdrawn1

Recruiting1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (15.4%)

Phase 11 (7.7%)

Phase 25 (38.5%)

Phase 42 (15.4%)

N/A3 (23.1%)

Trials by Status

terminated214%

withdrawn17%

recruiting17%

completed536%

enrolling_by_invitation17%

not_yet_recruiting321%

unknown17%

Recent Activity

1 active trials

Showing 5 of 14

not_yet_recruitingnot_applicable

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

NCT01594047

terminatedphase_2

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

NCT04613453

View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials

NCT06738043Not Applicable

Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery

Not Yet Recruiting

NCT05949554

Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.

Withdrawn

NCT04944017Phase 2

Ketamine for the Treatment of Depression in Parkinson's Disease

Completed

NCT01594047Not Applicable

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

Completed

NCT04613453Phase 2

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

Terminated

NCT06736769Phase 2

Ketamine Effects on Learning In Eating Disorders

Enrolling By Invitation

NCT07009158Phase 1

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Not Yet Recruiting

NCT06935552Early Phase 1

Ketamine and Lidocaine Infusion in Refractory Chronic Migraine

Not Yet Recruiting

NCT06774274Phase 4

Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain in Major Orthopedic Surgery.

Recruiting

NCT01480765Phase 4

Preventing Pain After Heart Surgery

Completed

NCT03889756Phase 2

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

Terminated

NCT03896256Early Phase 1

Ketamine for Refractory Chronic Migraine: a Pilot Study

Completed

NCT01100255Phase 2

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Completed

NCT01997801Not Applicable

Ketamine in Robot-assisted Thyroidectomy

Unknown

All 14 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 14